Literature DB >> 9886820

Angiotensin II receptors in human preadipocytes: role in cell cycle regulation.

D L Crandall1, D C Armellino, D E Busler, B McHendry-Rinde, J G Kral.   

Abstract

The role of angiotensin II (AII) in human preadipocyte physiology has been investigated in primary cultures from human adipose tissue. Receptor binding studies indicated that human preadipocytes express a high affinity AII binding site of the AT1 subtype, as binding of 125I-labeled [Sar1,Ile8]AII was rapid, saturable, and specific. As AII has previously been demonstrated to affect the cell cycle in adrenal and cardiac cells, the effect of AII on regulation of cycle progression was examined in human preadipocytes. Stimulation of preadipocytes with AII resulted in G1 phase progression of the cell cycle, as determined by flow cytometric analysis. AII treatment was associated with induction of expression of the messenger RNA for the cell cycle regulatory protein cyclin D1 in a dose-dependent manner. Pretreatment of cells with subtype-selective AT receptor ligands before AII stimulation indicated that the cyclin response was mediated via the AT1 receptor. The identity of the cells as preadipocyte was verified by culture in a defined differentiation medium, observing both leptin message expression and triglyceride accumulation by flow cytometry. These findings indicate that AII has early, receptor-mediated effects on cell cycle progression in human preadipocytes that may contribute to differentiation to the adipocyte phenotype.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9886820     DOI: 10.1210/endo.140.1.6430

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

Review 1.  Fat cell metabolism: insulin, fatty acids, and renin.

Authors:  L A Cassis
Journal:  Curr Hypertens Rep       Date:  2000-04       Impact factor: 5.369

2.  Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice.

Authors:  Frederique Yiannikouris; Michael Karounos; Richard Charnigo; Victoria L English; Debra L Rateri; Alan Daugherty; Lisa A Cassis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-11-09       Impact factor: 3.619

Review 3.  The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome.

Authors:  Tina Thethi; Masumi Kamiyama; Hiroyuki Kobori
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

Review 4.  Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a new pharmacotherapeutic target.

Authors:  Reza Aghamohammadzadeh; Sarah Withers; Fiona Lynch; Adam Greenstein; R Malik; Anthony Heagerty
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 5.  The renin angiotensin system and the metabolic syndrome.

Authors:  Annette D de Kloet; Eric G Krause; Stephen C Woods
Journal:  Physiol Behav       Date:  2010-04-08

Review 6.  Mechanisms mediating renal sympathetic nerve activation in obesity-related hypertension.

Authors:  W Chen; S Leo; C Weng; X Yang; Y Wu; X Tang
Journal:  Herz       Date:  2015-04       Impact factor: 1.443

7.  Differentiation and characterization of human facial subcutaneous adipocytes.

Authors:  Su-Hyoun Chon; Apostolos Pappas
Journal:  Adipocyte       Date:  2014-11-14       Impact factor: 4.534

Review 8.  Metabolic rate regulation by the renin-angiotensin system: brain vs. body.

Authors:  Justin L Grobe; Kamal Rahmouni; Xuebo Liu; Curt D Sigmund
Journal:  Pflugers Arch       Date:  2012-04-12       Impact factor: 3.657

9.  Changes of renal AT1/AT2 receptors and structures in ovine fetuses following exposure to long-term hypoxia.

Authors:  Caiping Mao; Jianquan Hou; Jianyi Ge; Yali Hu; Yang Ding; Yun Zhou; Huiying Zhang; Zhice Xu; Lubo Zhang
Journal:  Am J Nephrol       Date:  2009-11-18       Impact factor: 3.754

Review 10.  The adipose renin-angiotensin system: role in cardiovascular disease.

Authors:  Sean Thatcher; Frederique Yiannikouris; Manisha Gupte; Lisa Cassis
Journal:  Mol Cell Endocrinol       Date:  2009-04-29       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.